NL-OMON37181已完成不适用
An open label, part-randomised, four-way crossover, single and repeat dose study to determine the dose proportionality and absolute bioavailability of fluticasone furoate (FF) when administered as FF inhalation powder from the novel dry powder inhaler in healthy subjects. - Four-way crossover, single and repeat dosing BA and BE study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Healthy male or female
- •Between 18 and 65 years of age inclusive
- •BMI within the range 18.5-29.0 kg/m2 (inclusive).
排除标准
- •A positive pre-study Hepatitis B surface antigen or positive Hepatitis C antibody result within 3 months of screening.
- •A positive test for HIV antibody.
- •Where participation in the study would result in donation of blood or blood products in excess of 500 mL within a 56 day period.
研究者
相似试验
已完成
不适用
A randomized, open-label, four-way cross-over, single dose study to compare the pharmacokinetics of monomethyl fumarate and other metabolites after administration of dimethyl fumarate as a delayed- and slow-release formulation of FP187 and Tecfidera® in healthy volunteers.10029305Multiple SclerosisNL-OMON42906Forward Pharma GmbH24
已完成
1 期
A study in healthy volunteers to assess how the body takes up different recipes of the test medicine (alectinib)CancerISRCTN74516835Chugai Pharmaceutical Co., Ltd.29
招募中
1 期
A clinical trial to study the effect of SMC021 on the blood levels of ibuprofen and paracetamol and the effect of ibuprofen and paracetamol in blood levels of SMC021CTRI/2009/091/001052ovartis Healthcare Pvt Ltd56
已完成
不适用
clinical trial to investigate pharmacokinetic interaction between HGP0904, HGP0608 and HGP1405Diseases of the circulatory systemKCT0001693Hanmi Pharm28
已完成
4 期
A phase IV, randomized, open label, cross-over, intervention trial to investigate the effect of the switch of protease inhibitors to raltegravir on endothelial function, chronic inflammation, immune activation and HIV replication below 50 copies/mlNL-OMON39957niversitair Medisch Centrum Utrecht24